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SUMMARY 
A case which fulfilled the clinical description of Rabbit Syndrome investigated with sleep E.E.G 
is presented. Unlike the earlier reports, a patchy disappearance of the movement disorder during Stage 1 
NREM sleep was noticed. The clinical differentiating features from tardive dyskinesia are discussed. 
The "Rabbit Syndrome" described by 
Villeneuve (1972) as a late-onset neuro-
leptic-induced extrapyromidal syndrome, is 
characterised by rhythmic 5-5.5 per second 
involuntary movements of the oral and 
masticatory musculature that mimic the 
chewing movements of a rabbit. The rabbit 
syndrome is readily reversible with the 
discontinuation of neuroleptics (Villeneuve, 
1972) and responds to antiparkinsonian 
drugs (Sovner and Dimascio, 1977 ; Jus et 
al., 1979). There are reports that the 
Rabbit syndrome persists in stage I NREM 
sleep unlike tardive dyskinesia, another 
late-onset neuroleptic-induced movement 
disorder (Jus et al., 1972 ; Villeunve et al., 
1973). 
Case Report : 
Mr. S. R. a 38 year old unmarried 
male, consulted us on September 1980 
with a recent onset of movement disorder 
confining to jaw and lips. He was attending 
out-patient department of National Institute 
of Mental Health and Neuro Sciences, 
Bangalore from 1967 onwards after an acute 
psychotic episode and had been on anti-
psychotic medication as suggested to him 
from time to time. He had no past history 
of any significant physical illness. 
In 1967 he was treated with chlorpro-
mazine (300-500 mgm/day) and improved 
over a period of three months. He resumed 
his occupation and was drug-free until 
1973, when he developed a relapse of the 
psychotic illness with predominant schizo-
phrenic features. He was treated with 
Chlorpromazine (300 mgm/day) and tri-
fluperazine (15 mgm/day) and a course 
of 5 ECTS. Trihexyphenidyl (6 mgm/day) 
was added as he developed parkinsonian 
symptoms. Patient made a good social 
recovery and was maintained on the same 
drugs for a period of one year. 
He was alright till 1976 when he again 
developed florid schizophrenic features and 
had to be hospitalized. He was treated with 
trifluperazine (30 mgm/day) and Chlor-
promazine (100 mgm/day), and with a 
course of 6 ECTS. During his stay in 
hospital trihexyphenidyl (6 mgm/day) was 
added, as he developed parkinsonian symp-
toms. After discharge oral medications 
were gradually withdrawn and he was 
stabilized on fortnightly parenteral flu-
phenazine deconoate (25 mgm) and oral 
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trihexyphenidyl (4 mgm/day). He was 
maintaining good improvement and was 
on regular medications for four years. 
During this period, he had an exacerbation 
of psychotic symptoms and was prescribed 
haloperidol (15 mgm/day) in addition to 
the parenteral fluphenazine deconoate he 
had received a week earlier. It was six 
days after starting haloperidol, that he 
developed this movement disorder, for which 
consultation was sought. 
At the time of evaluation, his mental 
status did not reveal any overt psychotic 
features. On physical examination he had 
an involuntary movement disorder which 
confined bilaterally to the oral and mas-
ticatory musculature. The tongue was 
not involved. The movement was rhythmic 
and more at rest with a tendency to diminish 
while engaged in conversation. There were 
no other neurological abnormalities. The 
movement disorder was thought to be a 
recent onset tardive dyskinesia and he was 
admitted for detailed evaluation and treat-
ment. Patient continued to receive halo-
peridol in the ward. On the second day 
of admission the patient had developed 
rigidity, tremors and bradykinesia in addi-
tion to these masticatory movements. He 
was given promethazine (50 mg) parenteral 
and within 45 minutes the parkinsonian 
symptoms and these masticatory move-
ments disappeared completely. However 
the masticatory movement as such re-
appeared on the next day. At this stage a 
revised diagnosis of Rabbit syndrome was 
made as it fulfilled the clinical criteria. 
On the third day all drugs were withdrawn 
to facilitate a drug-free sleep EEG record. 
The sleep EEG was recorded with a 
muscle electrode over the jaw. The jaw 
movements were rhythmic with a frequency 
of six per second (fig. 1). It was also seen 
that the movement disorder was not cons-
tantly present in Stage I NREM sleep. 
There were occasions when the movement 
was totally absent during this stage of sleep 
and this disappearance was patchy with 
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Fig. 1.—E. E. G. tracings illustrating the relation between the involuntary movement and sleep. The last 
channel records artefacts from an electrode placed on the masseter. Recording done with "10-20 
electrode placement" TC 0.03 High Frequency filter 75. 
(a) awake, with 9-10 Hz alpha and 6 Hz myogenic artefacts. 
(A) fitage 1 NREM sleep, with absence of alpha and low index beta. Note the rhytmic 6 Hz in-
voluntary movement artefact, 
(c) Stage 1 NREM sleep with abundant beta, with disappearance of the involuntary movement. 100  B. N. GANGADHAR, et al. 
no prediliction for early, middle or late 
parts of this stage of sleep. From the fifth 
day of admission trihexyphenedyl (8 mgm 
per day) was started and the movement 
disorder disappeared totally. He was dis-
charged by the tenth day. He continued 
to remain symptom free on further weekly 
follow-ups without antipsychotics. Tri-
hexyphenedyl was withdrawn over a period 
of four weeks, and the movements did not 
reappear. 
COMMENTS 
The clinical description of this case is 
in keeping with the earlier description of 
Rabbit syndrome, including its response to 
antiparkinsonian drugs (Villenuve, 1972 ; 
Sovner and Dimascio, 1977 ; Jus et al., 
1979). As the movement did not persist 
throughout the stage I NREM sleep a 
differentiation from tardive dyskinesia needs 
to be made at a clinical level. Unlike 
Rabbit syndrome the initial movements of 
orofacial tardive dyskinesia occur in tongue 
and later spread to other parts (Ayd, 1967). 
Also tardive dyskinesia tends to worsen on 
withdrawal of neuroleptics and might even 
be suppressed by antipsychotics (Baldes-
sarini and Tarsy, 1975). Even though its 
early symptoms are completely reversible 
(Quitkin et al., 1977), tardive dyskinesia 
worsening with anticholingergic atniparkin-
sonian drugs is well emphasised (Baldessarini 
and Tarsy, 1975). The latter feature cer-
tainly differentiates Rabbit syndrome from 
tardive dyskinesia, as the former specifially 
improves with antiparkinsonian drugs. 
We maintain the view that the patho-
physiology of Rabbit syndrome is similar 
to that of the drug induced parkinsonism 
(Jus et al., 1972). The coexistance of the 
drug-induced parkinsonism and improve-
ment in both with antiparkinsonian drugs, 
as in this case substantiates this view. It 
is interesting to note that unlike drug-
induced parkinsonism Rabbit syndrome 
occurs as a late-onset neuroleptic induced 
movement disorder. Hence a separate 
terminology may be still valid. 
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